Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 4 | 13 | +0,11 % | ||
| REVOLUTION MEDICINES | 4 | 5 | +1,62 % | ||
| XENON PHARMACEUTICALS | 2 | - | -0,98 % | ||
| AMGEN | 1 | 27 | +0,03 % | ||
| MODERNA | 1 | 16 | +0,12 % | ||
| TRAVERE THERAPEUTICS | 1 | 11 | -1,15 % | ||
| COMPASS PATHWAYS | 1 | 11 | 0,00 % | ||
| NOVAVAX | 1 | 7 | -1,07 % | ||
| ZAI LAB LTD ADR | 1 | 6 | 0,00 % | ||
| GRIFOLS | 1 | 4 | -0,70 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04:26 | Revolution Medicines (RVMD) Jumps 54% on Stellar Drug Trial Results | 1 | Insider Monkey | ||
| 00:30 | Xenon Pharma's azetukalner shows 53% seizure reduction in trial | 1 | Investing.com | ||
| 00:26 | Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership | 4 | Insider Monkey | ||
| 00:26 | Here's What TD Cowen Thinks About Tempus AI Inc (TEM) Stock | 1 | Insider Monkey | ||
| 00:06 | Xenon Pharmaceuticals Inc.: Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting | 2 | GlobeNewswire (USA) | ||
| 00:06 | Immunocore Holdings plc: KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma | 1 | GlobeNewswire (USA) | ||
| So | Is Shah Capital's Criticism of Novavax Fair? A Wall Street Analyst Weighs In | 4 | MedCity News | ||
| So | Amneal rated Buy in new research coverage at UBS as growth pipeline expands | 4 | Seeking Alpha | ||
| So | Mesoblast Limited (MESO), One of the Best Long-Term ASX Stocks To Buy Right Now; See Why | 2 | Insider Monkey | ||
| So | Revolution Medicines: Starke Phase-1-Daten für Lungenkrebsmedikament treiben Aktie an | 8 | Investing.com Deutsch | ||
| So | Revolution Medicines reports phase 1 data for lung cancer drug | 3 | Investing.com | ||
| So | Revolution Medicines, Inc.: Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting | 5 | GlobeNewswire (USA) | ||
| So | Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy | 6 | Insider Monkey | ||
| So | Grifols (GRFS) Unveils AI-Driven Data for Early Parkinson's Disease Detection | 2 | Insider Monkey | ||
| So | Here is Why Travere (TVTX) is an Overlooked Growth Stocks to Buy Now | 1 | Insider Monkey | ||
| So | FDA Accepts Ultragenyx (RARE) BLA for Sanfilippo Syndrome Gene Therapy UX111 | 2 | Insider Monkey | ||
| So | Arcutis Biotherapeutics (ARQT) Presents Positive Phase 2 Data for ZORYVE Cream in Infants | 2 | Insider Monkey | ||
| So | ANAVEX LIFE SCIENCES CORP: Struktur in der Stille | 3 | Maximilian Berger | ||
| So | Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis' | 1 | Benzinga.com | ||
| So | ANALYSE: Curevac - Was hinter den Kulissen passiert - So reagieren erfahrene Anleger jetzt | Hebelschein-Spekulant |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.